Positron ships PET scanner to Japan

Article

Positron has shipped its PET scanner hardware platform, the Posicam-HZL, to the National Institute of Radiological Sciences of Japan. The equipment will be marketed and distributed by Imatron-Japan. The center will use the Posicam-HZL in oncology

Positron has shipped its PET scanner hardware platform, the Posicam-HZL, to the National Institute of Radiological Sciences of Japan. The equipment will be marketed and distributed by Imatron-Japan.

The center will use the Posicam-HZL in oncology and cardiology research, said Dr. Katsuya Yoshida of Japan's Division of Advanced Technology for Medical Imaging. Imatron-Japan president Sachiko Kinoshita said she expects interest in PET scanners to increase in that country.

Imatron, a South San Francisco-based company that creates electron beam tomography scanners, has a 16% interest in Houston-based Positron.

Positron has reported an increase in revenue for first quarter 2000 (end March 31) of 200% over the same period last year. Revenue was $1.2 million in this period compared with revenue of $388,000 for first quarter 1999. The company ascribes the increase in revenue to the shipment of one Posicam system; it did not ship any Posicam systems in the first quarter of 1999. Positron reported a net loss of $157,000 in the first quarter of 2000, which it attributed to increased staff and related operation expenditures. This was compared to net income of $34,000 in the first quarter of 1999.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.